Impact of Brain Metastases in Immune Checkpoint Inhibitors (ICI) Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

被引：1
|
作者：
Hendriks, L. [1 ]
Henon, C. [2 ]
Auclin, E. [3 ]
Mezquita, L. [4 ]
Ferrara, R. [4 ]
Audigier-Valette, C. [5 ]
Mazieres, J. [6 ]
Lefebyre, C. [6 ]
Le Moulec, S. [7 ]
Cousin, S. [7 ]
Duchemann, B. [8 ]
Le Pechoux, C. [9 ]
Botticella, A. [10 ]
Ammari, S. [11 ]
Gazzah, A. [2 ]
Caramella, C. [11 ]
Adam, J. [12 ]
Planchard, D. [2 ]
De Ruysscher, D. [13 ]
Dingemans, A. [14 ]
Besse, B. [15 ]
机构：
[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[2] Gustave Roussy, Med Oncol, Villejuif, France
[3] Hop Europeen Georges Pompidou, Gastrointestinal & Med Oncol Dept, Paris, France
[4] Gustave Roussy, Med Oncol Dept, Villejuif, France
[5] Hop St Musse, Toulon, France
[6] Hop Larrey, Toulouse, France
[7] Inst Bergonie, Bordeaux, France
[8] Hop Avicenne, Dept Pulm Dis 7, Bobigny, France
[9] Gustave Roussy, Radiat Oncol, Villejuif, France
[10] Gustave Roussy, Radiotherapy, Villejuif, France
[11] Gustave Roussy, Radiol, Villejuif, France
[12] Gustave Roussy, Pathol, Villejuif, France
[13] Maastricht Univ, Med Ctr, Radiat Oncol, Maastro Clin, Maastricht, Netherlands
[14] Maastricht Univ, Med Ctr, Pulm Dis, Maastricht, Netherlands
[15] Gustave Roussy, Dept Canc Med, Villejuif, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Immunotherapy; NSCLC; brain metastases;
D O I：
10.1016/j.jtho.2018.08.382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.09
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] Impact of central nervous system (CNS) involvement in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI).
    Hendriks, Lizza
    Henon, Clemence
    Mezquita, Laura
    Auclin, Edouard
    Ferrara, Roberto
    Audigier-Valette, Clarisse
    Le Pechoux, Cecile
    Botticella, Angela
    Ammari, Samy
    Gazzah, Anas
    Caramella, Caroline
    Adam, Julien
    Planchard, David
    Dingemans, Anne-Marie C.
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Impact of early introduction of steroid on immune-checkpoint inhibitors (ICI) in patients with advanced non-small cell lung cancer treated
    De Giglio, A.
    Mezquita, L.
    Auclin, E.
    Blanc-Durand, F.
    El-Amarti, L.
    Caramella, C.
    Bernal, G. Martinez
    Hendriks, L.
    Ferrara, R.
    Naltet, C.
    Lavaud, P.
    Gazzah, A.
    Adam, J.
    Planchard, D.
    Chaput, N.
    Besse, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [4] Impact of Mutation Class and Smoking Status in BRAFMutant Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibitors (ICI)
    Marin-Acevedo, J. A.
    Bandikatla, S. V.
    Thapa, R.
    Puri, S.
    Chen, D. -T.
    Hicks, K.
    Gray, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S259 - S260
  • [5] IMPACT OF STEROIDS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES
    Thapa, Bicky
    Lauko, Adam
    Borghei-Razavi, Hamid
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Pennell, Nathan
    Velcheti, Vamsidhar
    Angelov, Lilyana
    Mohammadi, Alireza
    Vogelbaum, Michael
    Barnett, Gene
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2018, 20 : 55 - 55
  • [6] Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
    Hendriks, Lizza E. L.
    Henon, Clemence
    Auclin, Edouard
    Mezquita, Laura
    Ferrara, Roberto
    Audigier-Valette, Clarisse
    Mazieres, Julien
    Lefebvre, Corentin
    Rabeau, Audrey
    Le Moulec, Sylvestre
    Cousin, Sophie
    Duchemann, Boris
    le Pechoux, Cecile
    Botticella, Angela
    Ammari, Samy
    Gazzah, Anas
    Caramella, Caroline
    Adam, Julien
    Lechapt, Emmanuele
    Planchard, David
    De Ruysscher, Dirk
    Dingemans, Anne-Marie
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) : 1244 - 1254
  • [7] Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Li, Xing
    Wang, Lei
    Chen, Shanhao
    Zhou, Fei
    Zhao, Jing
    Zhao, Wencheng
    Su, Chunxia
    THORACIC CANCER, 2020, 11 (10) : 2812 - 2819
  • [8] Clinical predictive factors in real world setting in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Callejo, A.
    Marmolejo, D.
    Iranzo, P.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S766 - S766
  • [9] Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)
    Iranzo, P.
    Callejo, A.
    Marmolejo, D.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S767 - S767
  • [10] Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases
    Wei Yuxi
    Xu Yan
    Wang Mengzhao
    中华医学杂志英文版, 2023, 136 (13)
12345